T. Rowe Price Reports 4.51% Stake in QIAGEN
T. Rowe Price reported a 4.51% capital interest and 4.51% voting rights in QIAGEN. The transaction date was October 30, 2026.
T. Rowe Price reported a 4.51% capital interest and 4.51% voting rights in QIAGEN. The transaction date was October 30, 2026.